EDE FederalFederal Decree-Law No. 38 of 2024
Federal Decree-Law No. 38 of 2024 is the official EDE identifier for “Federal Decree-Law Governing Medical Products, Pharmacists and Pharmaceutical Establishments”. Federal Decree-Law No. 38 of 2024 is the official identifier EDE uses for this instrument.
- Instrument
- Federal
- Full name
- Federal Decree-Law No. 38 of 2024
- Category
- General
- Authority source
- English
- Readable HTML
- Not available yet
- Published
- 2024
- Effective
- 2025-01-02
Federal Decree-Law Governing Medical Products, Pharmacists and Pharmaceutical Establishments
Successor primary law for medical products (including Medical Equipment) in the UAE, repealing Federal Law No. 8 of 2019 (Article 180) and in force from 2 January 2025 (Article 181). Establishes the Emirates Drug Establishment (EDE) as the federal regulator (marketing approvals, licensing, import permits, pharmacovigilance) with the Ministry and local health authorities. The official English expression is published in full on the UAE legislation portal (verified in full — Parts One to Nine, 181 articles), but the portal returns a Cloudflare 403 to ingestion clients and the EDE-hosted Arabic original PDF has a visually scrambled text layer that is not publishable. This is therefore a blocked exact source, not a virtual corpus view.
Federal Decree-Law No. 38 of 2024 is the official identifier EDE uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.